carnitine has been researched along with Neurodevelopmental Disorders in 2 studies
Neurodevelopmental Disorders: These are a group of conditions with onset in the developmental period. The disorders typically manifest early in development, often before the child enters grade school, and are characterized by developmental deficits that produce impairments of personal, social, academic, or occupational functioning. (From DSM-5).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Wenger, O | 1 |
Brown, M | 1 |
Smith, B | 1 |
Chowdhury, D | 1 |
Crosby, AH | 1 |
Baple, EL | 1 |
Yoder, M | 1 |
Laxen, W | 1 |
Tortorelli, S | 1 |
Strauss, KA | 1 |
Lv, QQ | 1 |
You, C | 1 |
Zou, XB | 1 |
Deng, HZ | 1 |
2 other studies available for carnitine and Neurodevelopmental Disorders
Article | Year |
---|---|
Biochemical phenotype and its relationship to treatment in 16 individuals with PCCB c.1606A > G (p.Asn536Asp) variant propionic acidemia.
Topics: Acids; Adolescent; Adult; Amino Acids; Biomarkers; Carbon-Carbon Ligases; Carnitine; Child; Child, P | 2020 |
Acyl-carnitine, C5DC, and C26 as potential biomarkers for diagnosis of autism spectrum disorder in children.
Topics: Autism Spectrum Disorder; Biomarkers; Carnitine; Child; Child, Preschool; China; Female; Humans; Int | 2018 |